Can targeted addiction care prevent alcohol relapse after liver transplant?
NCT ID NCT05322226
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a personalized addiction monitoring program helps liver transplant patients avoid serious alcohol relapse one year after surgery. Researchers will follow 64 adults who are being evaluated for a liver transplant at a French hospital. The program includes medication, therapy, and flexible hospital stays, aiming to improve long-term health and survival.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADDICTION, ALCOHOL are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of hepato-gastroenterology and liver transplantation
Montpellier, Occitanie, 34090, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Ear device aims to cut opioid use after liver transplant
- Can we predict diabetes after a liver transplant?
- Text alerts could save transplanted organs in young patients
- Can a parenting class help families struggling with alcohol addiction?
- New program aims to curb teen binge drinking before it starts
- Belly wall transplants: a new frontier in organ transplants?